Mitchell Shawnte
Insider CIK 1749432 · ZGNX EVP, GC and Secretary · APVO SVP, GC and Corporate Affairs · OLMA CHIEF LEGAL OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2026-03-04 | 2026-03-05 | 25,000 | — | $0 | 410,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-03-04 | 2026-03-05 | 24,767 | $24.25 | $600.6K | 233 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2026-03-04 | 2026-03-05 | 25,000 | $4.37 | $109.3K | 25,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-03-04 | 2026-03-05 | 233 | $24.69 | $5.8K | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise deriv | 2026-03-03 | 2026-03-05 | 15,000 | — | $0 | 435,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | M Exercise | 2026-03-03 | 2026-03-05 | 15,000 | $4.37 | $65.5K | 15,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | S Sale | 2026-03-03 | 2026-03-05 | 15,000 | $23.01 | $345.1K | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 220,000 | — | $0 | 220,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 56,250 | — | $0 | 56,250 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-02-28 | 2025-03-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 25,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 25,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 110,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | U Tender | 2022-03-07 | 2022-03-09 | 605 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-03-26 | 2021-03-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-03-26 | 2021-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-04-20 | 2020-04-21 | 110,000 | — | $0 | 110,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-02-18 | 2020-03-19 | 134,800 | — | $0 | 134,800 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-11-01 | 2019-11-05 | 120,968 | — | $0 | 120,968 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2019-03-01 | 2019-03-04 | 6,787 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2019-03-01 | 2019-03-04 | 2,012 | $1.57 | $3.2K | 80,527 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2019-03-01 | 2019-03-04 | 6,787 | — | $0 | 82,539 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 67,400 | — | $0 | 67,400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-08-09 | 2018-08-13 | 1,630 | — | $0 | 6,787 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2018-08-09 | 2018-08-13 | 383 | $4.50 | $1.7K | 75,752 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-08-09 | 2018-08-13 | 1,630 | — | $0 | 76,135 | SEC↗ |